Go Pro

Passage Bio (PASG) Institutional Ownership

Passage Bio logo
$4.51 +0.07 (+1.58%)
Closing price 04:00 PM Eastern
Extended Trading
$4.53 +0.02 (+0.33%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Passage Bio (NASDAQ:PASG)

Current
Institutional Ownership
Percentage
53.48%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$2.73M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$190.09M
Get PASG Insider Trade Alerts

Want to know when executives and insiders are buying or selling Passage Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PASG Institutional Buying and Selling by Quarter

Passage Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/18/2026 Eversept Partners LP131,581$1.03M0.1%+4.2%4.099%
5/14/2026 Renaissance Technologies LLC133,612$1.05M0.0%+22.5%4.162%
2/18/2026 Yiheng Capital Management L.P.34,301$405K0.1%N/A1.079%
2/18/2026 Quadrature Capital Ltd12,578$148K0.0%N/A0.396%
2/18/2026 Eversept Partners LP126,230$1.49M0.1%N/A3.971%
2/16/2026 Squarepoint Ops LLC10,799$127K0.0%-54.0%0.340%
2/12/2026 Renaissance Technologies LLC109,089$1.29M0.0%+8.2%3.430%
2/11/2026 Erste Asset Management GmbH85,262$1.00M0.0%-30.6%2.681%
2/9/2026 Geode Capital Management LLC31,397$371K0.0%+15.1%0.987%
2/6/2026 Nano Cap New Millennium Growth Fund L P10,000$118K0.1%N/A0.314%
11/17/2025 Vestal Point Capital LP305,000$2.45M0.1%-95.0%9.591%
11/17/2025 Citadel Advisors LLC19,091$153K0.0%-92.7%0.600%
11/14/2025 Orbimed Advisors LLC59,046$474K0.0%-99.0%1.857%
11/14/2025 Fiduciary Trust Co10,750$86K0.0%-95.0%0.338%
11/14/2025 Bridgeway Capital Management LLC20,803$167K0.0%-95.0%0.654%
11/14/2025 Squarepoint Ops LLC23,500$188K0.0%N/A0.739%
11/13/2025 Lynx1 Capital Management LP623,704$5.01M1.0%-93.3%19.613%
11/12/2025 Erste Asset Management GmbH122,790$999K0.0%-95.0%3.861%
8/15/2025 Bridgeway Capital Management LLC416,042$167K0.0%-17.8%13.083%
8/14/2025 Orbimed Advisors LLC6,055,300$2.42M0.1%-13.9%194.080%
8/8/2025 Geode Capital Management LLC538,578$216K0.0%-1.4%17.262%
5/12/2025Simplex Trading LLC82,346$29K0.0%+9,311.0%0.132%
2/17/2025Squarepoint Ops LLC64,099$36K0.0%+129.5%0.104%
2/17/2025Two Sigma Investments LP49,364$28K0.0%-49.6%0.080%
2/17/2025Shay Capital LLC225,261$128K0.0%+144.2%0.365%
2/17/2025Orbimed Advisors LLC7,404,869$4.20M0.1%-24.6%11.988%
2/14/2025Jane Street Group LLC78,190$44K0.0%+537.2%0.127%
2/14/2025Northern Trust Corp62,476$35K0.0%+55.1%0.101%
2/14/2025Lynx1 Capital Management LP9,256,953$5.25M2.0%+9.8%14.986%
2/14/2025Tower Research Capital LLC TRC54,479$31K0.0%+983.1%0.088%
2/12/2025Geode Capital Management LLC531,565$302K0.0%+4.3%0.861%
11/16/2024Geode Capital Management LLC509,516$357K0.0%+18.2%0.825%
11/15/2024Erste Asset Management GmbH2,455,800$1.72M0.0%N/A3.976%
11/14/2024Vestal Point Capital LP6,100,000$4.27M0.3%+0.8%9.876%
11/9/2024Landscape Capital Management L.L.C.53,915$38K0.0%N/A0.087%
8/15/2024Lynx1 Capital Management LP5,057,629$4.02M1.5%+4.4%8.188%
8/9/2024Renaissance Technologies LLC1,125,574$894K0.0%-6.6%1.826%
8/8/2024Versant Venture Management LLC4,026,417$3.20M4.1%-18.8%6.532%
5/30/2024Lynx1 Capital Management LP4,845,871$6.54M1.7%+1,178.1%7.862%
5/20/2024Virtu Financial LLC25,425$34K0.0%-62.4%0.041%
Why major institutions are piling into this digital asset now (Ad)

BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel

Get the name, the ticker, and exactly how to buy it
5/15/2024Affinity Asset Advisors LLC264,266$357K0.0%N/A0.429%
5/10/2024Acadian Asset Management LLC961,271$1.30M0.0%+59.0%1.560%
5/10/2024Vanguard Group Inc.2,071,538$2.80M0.0%+2.6%3.362%
2/14/2024Pale Fire Capital SE581,257$587K0.1%+489.1%1.060%
11/14/2023Lynx1 Capital Management LP190,124$125K0.1%-83.7%0.347%
11/13/2023Acadian Asset Management LLC604,678$396K0.0%+4.5%1.103%
8/11/2023Pale Fire Capital SE98,662$93K0.0%N/A0.180%
7/24/2023BML Capital Management LLC2,058,767$1.94M1.7%+510.1%3.768%
5/1/2023Marquette Asset Management LLC86,050$82K0.0%+28.2%0.158%
4/12/2023Vontobel Holding Ltd.80,000$77K0.0%+128.6%0.146%
2/13/2023BML Capital Management LLC337,467$466K0.4%N/A0.619%
2/10/2023New York Life Investment Management LLC182,978$253K0.0%+12.7%0.335%
2/2/2023Bailard Inc.156,900$217K0.0%N/A0.288%
2/1/2023Bank of Montreal Can49,114$70K0.0%N/A0.090%
1/12/2023Marquette Asset Management LLC67,101$93K0.0%N/A0.123%
11/14/2022Annandale Capital LLC40,000$50K0.0%N/A0.073%
11/14/2022Lynx1 Capital Management LP2,752,422$3.44M3.1%+553.1%5.054%
11/14/2022Ergoteles LLC76,061$95K0.0%-54.8%0.140%
11/10/2022Connor Clark & Lunn Investment Management Ltd.87,832$110K0.0%+117.8%0.161%
11/4/2022Russell Investments Group Ltd.40,679$50K0.0%-53.0%0.075%
8/16/2022Woodline Partners LP1,788,059$4.22M0.1%-6.6%3.283%
8/11/2022Healthcare of Ontario Pension Plan Trust Fund200,300$473K0.0%-43.7%0.368%
8/5/2022Connor Clark & Lunn Investment Management Ltd.40,321$95K0.0%-12.9%0.074%
7/29/2022Russell Investments Group Ltd.86,515$204K0.0%+269.7%0.159%
5/17/2022Great Point Partners LLC113,900$353K0.1%-92.5%0.210%
5/16/2022Deep Track Capital LP3,375,000$10.46M0.7%+4.9%6.215%
5/16/2022Frazier Life Sciences Management L.P.5,009,219$15.53M1.3%N/A9.224%
5/12/2022Connor Clark & Lunn Investment Management Ltd.46,303$144K0.0%+98.6%0.085%
5/11/2022GSA Capital Partners LLP68,039$211K0.0%+194.7%0.125%
5/5/2022Russell Investments Group Ltd.23,400$72K0.0%N/A0.043%


PASG Institutional Ownership - Frequently Asked Questions

During the previous two years, 21 institutional investors and hedge funds held shares of Passage Bio. The most heavily invested institutionals were Lynx1 Capital Management LP ($5.01M), Vestal Point Capital LP ($2.45M), Renaissance Technologies LLC ($1.05M), Eversept Partners LP ($1.03M), Erste Asset Management GmbH ($1.00M), Orbimed Advisors LLC ($474K), and Yiheng Capital Management L.P. ($405K).Learn more on Passage Bio's institutional investors.

53.48% of Passage Bio's stock is owned by institutional investors. Learn more on PASG's institutional investor holdings.

Of the 16 institutional investors that purchased Passage Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Erste Asset Management GmbH ($2.46M), Lynx1 Capital Management LP ($830.00K), Shay Capital LLC ($133.01K), Eversept Partners LP ($131.58K), Geode Capital Management LLC ($104.57K), Simplex Trading LLC ($81.47K), and Jane Street Group LLC ($65.92K).

Institutional investors have bought a total of 248,897 shares in the last 24 months. This purchase volume represents approximately $2.73M in transactions.

The following institutional investors have sold Passage Bio stock in the last 24 months: Lynx1 Capital Management LP ($8.63M), Orbimed Advisors LLC ($6.00M), Vestal Point Capital LP ($5.80M), Erste Asset Management GmbH ($2.37M), Bridgeway Capital Management LLC ($395.24K), Citadel Advisors LLC ($241.09K), and Fiduciary Trust Co ($204.25K).

Institutional investors have sold a total of 23,648,322 shares in the last 24 months. This volume of shares sold represents approximately $190.09M in transactions.



Institutional ownership data for NASDAQ:PASG is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 5/18/2026. New 13F filings are added each quarter as they're published.
From Our Partners